Greenway Vision October 29th | Shandong Sinobioway Biomedicine (002581.SZ) announced its third quarter report for 2024, achieving revenue of 0.315 billion yuan in the first three quarters, a decrease of 6.99% year-on-year; net income attributable to shareholders of listed companies was 14.6263 million yuan, a decrease of 50.78% year-on-year; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was 16.5706 million yuan, a decrease of 49.02% year-on-year; basic earnings per share was 0.0222 yuan.
未名医药(002581.SZ)：前三季度净利润1462.63万元 同比下降50.78%
Shandong Sinobioway Biomedicine (002581.SZ): net income for the first three quarters was 14.6263 million yuan, a year-on-year decrease of 50.78%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated